NCT00980382View on ClinicalTrials.gov

A Phase I/II Study of S-1 and Weekly Docetaxel for Metastatic Gastric Carcinoma

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

85

Participants

Timeline

Start Date

September 30, 2004

Primary Completion Date

August 31, 2007

Study Completion Date

August 31, 2007

Conditions
Stomach Neoplasms
Interventions
DRUG

S-1, Docetaxel

"* Phase I study~ * S-1 (level 0, 1/2, 3/4, 5: 60, 70, 80, 90 mg/m2/day) q 12 hours po Days 1-14~ * Docetaxel (level 0/1,2/3, 4/5: 25, 30, 35 mg/m2) iv : Days 1, 8~* Phase II study~ * S-1 (80mg/m2/day) q 12 hours po Days 1-14~ * Docetaxel (35 mg/m2) iv : Days 1, 8"

Trial Locations (1)

Unknown

National Cancer Center Korea, Goyang-si

All Listed Sponsors
lead

National Cancer Center, Korea

OTHER_GOV

NCT00980382 - A Phase I/II Study of S-1 and Weekly Docetaxel for Metastatic Gastric Carcinoma | Biotech Hunter | Biotech Hunter